DOI: 10.1038/s41598-018-32032-x, Wicinski, M., Gebalski, J., Golebiewski, J., and Malinowski, B
These symptoms typically resolve within 24 hours.* Not for Everyone: This therapy is not recommended for individuals allergic to cobalamin (B12), those with liver disease, or those currently taking medications that interact with methyl donors
BPC-157 Experimental Use in Pollinator Studies Unconventional research has explored BPC-157 in the context of bee colony collapse disorder
The quality of the ingredients has not been tested
A large proportion of patients experience moderate to severe pain, which often impacts quality of life more than objective disease severity
No FDA approval: IGF-1 LR3 has never received regulatory approval for human therapeutic use and is restricted to research applications [12]